funding-eu EU Horizon Europe HORIZON-MISS-2026-02 HORIZON-MISS-2026-02-CANCER-03 Anticancer therapy Diagnostic tools (e.g. genetic, imaging) Haematology

Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

EU — Italia · scadenza 15/09/2026

Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Scadenza: 15/09/2026

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

EU Programme: Horizon Europe (ID 43108390)
Call identifier: HORIZON-MISS-2026-02
Call name: Supporting the implementation of the Cancer Mission
Type: Topic
Opening date: 10/02/2026
Next deadline: 15/09/2026
Keywords: HORIZON-MISS-2026-02-CANCER-03, HORIZON-MISS-2026-02, Anticancer therapy, Diagnostic tools (e.g. genetic, imaging), Haematology, Medical devices, Paediatrics, Pharmacogenomics

Topic description

Expected Outcome:

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

Patients with refractory cancers and their caregivers/families will have access to optimised, tailored and affordable immunotherapeutic interventions that increase their quality of life, across European regions, EU Member States and Associated Countries;
Healthcare professionals and academia will have access

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora